Sound Income Strategies LLC Acquires 15,638 Shares of National Health Investors, Inc. $NHI

Sound Income Strategies LLC boosted its holdings in National Health Investors, Inc. (NYSE:NHI) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 256,898 shares of the real estate investment trust’s stock after purchasing an additional 15,638 shares during the period. National Health Investors makes up 1.0% of Sound Income Strategies LLC’s portfolio, making the stock its 29th largest position. Sound Income Strategies LLC owned 0.54% of National Health Investors worth $20,595,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its stake in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after acquiring an additional 288 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 136 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of National Health Investors during the third quarter valued at about $65,000. Triumph Capital Management bought a new position in shares of National Health Investors during the third quarter valued at about $66,000. Finally, Farther Finance Advisors LLC raised its stake in shares of National Health Investors by 24.9% during the third quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock valued at $90,000 after acquiring an additional 225 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Price Performance

Shares of NYSE NHI opened at $82.95 on Tuesday. National Health Investors, Inc. has a 1 year low of $66.41 and a 1 year high of $91.38. The company has a debt-to-equity ratio of 0.76, a current ratio of 6.90 and a quick ratio of 6.90. The company’s 50-day moving average is $84.84 and its 200 day moving average is $79.97. The stock has a market capitalization of $4.02 billion, a P/E ratio of 27.47, a P/E/G ratio of 4.51 and a beta of 0.63.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. During the same quarter in the prior year, the firm earned $1.24 EPS. National Health Investors’s quarterly revenue was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, sell-side analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be given a dividend of $0.92 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.4%. National Health Investors’s payout ratio is currently 121.85%.

Analysts Set New Price Targets

NHI has been the subject of several recent analyst reports. Wells Fargo & Company upped their price objective on shares of National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a research note on Friday, March 27th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a research note on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 price objective on shares of National Health Investors in a research note on Monday, January 5th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Finally, Truist Financial upped their price objective on shares of National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and an average price target of $86.83.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.